Which factor would you monitor to predict response for drugs with active metabolites?

• A. Concentrations of the active metabolites
• B. Total drug concentration
• C. Only parent drug
• D. Only inactive metabolites

Answer: (A)

When the pharmacologic effect is driven by active metabolites, predicting response hinges on the exposure to those active forms rather than the parent drug alone. The active metabolite can be formed at different rates in different people and may have its own potency and half-life, so measuring its concentration provides a more accurate link to efficacy and toxicity. Total drug concentration can mislead you, because a large amount of parent drug might be inactive or rapidly converted to an active metabolite, or vice versa; focusing on the parent only misses the part that actually produces the effect. If you monitor the concentrations of the active metabolites, you capture the true pharmacodynamic exposure that governs response. For example, some prodrugs rely on metabolite formation for effect, so the active metabolite level better predicts therapeutic outcomes than the parent drug level.